Largason, Lerma C.
HRN: 25-58-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
CEFUROXIME 1.5GM (VIAL)
08/06/2024
08/13/2024
IVT
1.5gms
Now Then Q 8 Hrs
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes